An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy
Clinical trial NCT01454531 · COMPLETED
Trial details
- NCT number
- NCT01454531
- Sponsor
- ALK-Abelló A/S
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-01
- Primary completion
- 2012-03-01
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.